KXVC

KXVC is an early-stage venture fund with limited public information beyond a website, LinkedIn, Twitter, and Crunchbase profile, operating in the seed and Series A range. Public footprint suggests a small institutional or syndicate-style fund rather than a large traditional VC. Plausible check sizes are $250K to $1.5M at seed and Series A, typically as a co-investor with selective small lead capacity. Healthcare exposure cannot be characterized confidently from public sources; founders should ask directly about prior healthcare investments and reference portfolio CEOs before progressing. AI focus is undeclared. Founders best suited are seed and Series A CEOs raising priced rounds with an institutional lead, who want a small high-conviction check from a partner with an active network. Founders who do not fit include therapeutics, devices, capital-intensive businesses, and growth-stage rounds. Geographic preference appears to be US with no obvious regional bias from public sources. The entry path is warm introduction through a portfolio CEO or a co-investor, with LinkedIn or Twitter outreach to a principal as a secondary option for founders with strong traction. Founders should not expect KXVC to lead, and the firm is best deployed as supplemental capital alongside a healthcare-native anchor. Founders looking for healthcare-specific operational support, regulatory expertise, or significant follow-on capital should plan to lead with a different investor and use KXVC only as a small supplemental check after an anchor is committed. Validate fund pacing and active deployment before significant time investment.